Lets Talk Finances

Provoking Discussion on Personal Finance and Investing

KALA - Kala Pharmaceuticals, Inc. ()

Overview

Company Summary


Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for various eye diseases. They are driven by the mission to transform the way patients with eye conditions are treated and improve their quality of life.

Kala Pharmaceuticals specializes in developing therapies using their proprietary Mucus Penetrating Particle (MPP) technology. This technology allows drugs to penetrate the protective mucus barrier within the eyes and delivers them directly to the targeted tissues, enhancing drug efficacy and reducing the need for frequent dosing.

The company has developed a number of product candidates for different eye conditions. Their lead product is INVELTYS, which is an FDA-approved corticosteroid for the treatment of inflammation and pain following eye surgery. INVELTYS provides a convenient and effective option for patients undergoing ocular surgery.

Kala Pharmaceuticals is also developing EYSUVIS, another corticosteroid product candidate, for the short-term treatment of dry eye disease flare-ups. Dry eye disease is a chronic condition that affects the quantity or quality of tears produced by the eyes, causing discomfort and vision problems. EYSUVIS aims to provide quick relief during these flare-ups.

Additionally, the company is exploring other therapeutic areas within ophthalmology, including retinal diseases and glaucoma, to develop innovative solutions for unmet medical needs.

With a focus on innovation, Kala Pharmaceuticals aims to bring novel treatment options to patients in the field of ophthalmology, addressing common eye diseases and improving the overall standard of care.

Notes (see all)

News